Publication | Closed Access

Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response

First-episode SchizophreniaPsychiatryRisk PredictionMedicinePsychotic DisorderPsychiatric GeneticsPsychopharmacologySchizophreniaNeuropsychiatrySocial SciencesNeuroscienceNegative Symptom Response5-Ht2c Receptor PolymorphismsPharmacologyPsychopathology